Risk-benefit/cost-benefit : improving government regulation of approval of new drugs

Author(s)

• Ricardo-Campbell, Rita

Bibliographic Information

Risk-benefit/cost-benefit : improving government regulation of approval of new drugs

remarks by Rita Ricardo-Campbell, presented at the World Congress on Health and Economics [i.e. World Congress on Health Economics] Leyden University, Leyden, The Netherlands, September 9, 1980

Hoover Institution, Stanford University, 1980

Note

Includes bibliographical references

Details

• NCID: BA06868051
• LCCN: 81166055
• Country Code: us
• Title Language Code: eng
• Text Language Code: eng
• Place of Publication: [Sanford, Calif.]
• Pages/Volumes: 21 p.
• Size: 23 cm
• Classification:
  • LCC : RA401.A3
  • DC19 : 363.1/946/0973
• Subject Headings:
  • LCSH : Pharmaceutical policy -- United States
  • LCSH : Drugs -- Testing -- Government policy -- United States
  • LCSH : Drugs -- Cost effectiveness
  • LCSH : Drugs -- United States -- Cost effectiveness